Search Results
Results found for "Institute for Research in Immunology and Cancer"
Posts (387)
- Fluorescence Polarization in GPCR Research
How Fluorescence Polarization Assays Work: Principles and Applications in GPCR Research FP assays work Ligands Looking ahead, fluorescence polarization technology is expected to expand its role in GPCR research
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
September 2022 "T cells are master regulators of the immune response tuning, among others, B cells, macrophages and NK cells. To exert their functions requiring high sensibility and specificity, T cells need to integrate different stimuli from the surrounding microenvironment. A finely tuned signalling compartmentalization orchestrated in dynamic platforms is an essential requirement for the proper and efficient response of these cells to distinct triggers. During years, several studies have depicted the pivotal role of the cytoskeleton and lipid microdomains in controlling signalling compartmentalization during T cell activation and functions. Here, we discuss mechanisms responsible for signalling amplification and compartmentalization in T cell activation, focusing on the role of CD28, chemokine receptors and the actin cytoskeleton. We also take into account the detrimental effect of mutations carried by distinct signalling proteins giving rise to syndromes characterized by defects in T cell functionality." Read more at the source #DrGPCR #GPCR #IndustryNews
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
Why Purpose Matters in Science For some researchers, science is a job. For others, it’s a calling. , Catherine reflects on how her identity as a scientist took shape, why she’s committed to academic research That alignment between curiosity and urgency set her on the path toward doctoral research. What’s Next in Her Opioid Research Catherine’s current experiments focus on outcomes such as respiratory Catherine’s story shows that when purpose drives research, science becomes more than a job—it becomes
Other Pages (220)
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
ABOUT THE GUEST Michel Bouvier is CEO of the Institut de Recherches Cliniques de Montreal (IRCM) and Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Institute for Research in Immunology and Cancer ( IRIC ) at the Université de Montréal. Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. He has supervised the research work of 75 graduate students and 40 post-doctoral fellows.
- Celtarys Research | Dr. GPCR Ecosystem
Learn about Celtarys Research through the Dr. GPCR Ecosystem. Visit Website About Celtarys Research Celtarys Research develops and commercializes new chemical tools are involved in several pathologies, ranging from neurological, oncological, degenerative, metabolic, immunological , CEO of Celtarys Research. /celtarys-research Services & Expertise NEW!
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
In pancreatic cancer, proton-sensing GPCRs such as GPR68 are dramatically upregulated in cancer-associated in animal models, particularly in pancreatic cancer. cancer-associated fibroblasts — not the cancer cells themselves. , immunology, and systems biology. Paul Insel on the web Insel Laboratory Institute of Engineering in Medicine UC San Diego UCSD Profiles






